使用神经网络算法预测妊娠糖尿病复杂妊娠中不良周产期结果
Ohad Houri1,2, Yotam Gil3, Eyal Krispin1,2
1Helen Schneider Hospital for Women, Rabin Medical Center, Petach-Tikva, Israel.
概括
这项研究开发了一种神经网络模型,用于预测妊娠期糖尿病 (GDM) 怀孕中新生儿不良结果. 该模型实现了高精度,识别了改善母婴护理的关键风险因素.
科学领域:
- 产周医学 产周医学
- 医疗保健中的人工智能
- 孕产妇与胎儿的医学
背景情况:
- 孕期糖尿病 (GDM) 是一种影响母亲和新生儿健康的严重并发症.
- 预测GDM怀孕中新生儿不良后果仍然是一个临床挑战.
- 早期识别高风险妊娠对于及时干预至关重要.
研究的目的:
- 开发和验证一种神经网络模型,用于预测GDM怀孕中新生儿不良结果.
- 确定GDM怀孕中新生儿不良结果的关键预测因素.
- 改进GDM的风险分层和管理策略.
主要方法:
- 使用基于XGBoost的神经网络模型,在Python 3.6中与Keras和TensorFlow实现.
- 来源数据来自2012-2016年间452名被诊断为GDM的个人.
- 包括怀孕参数,母亲人口统计,葡萄糖耐受性测试结果和血糖控制数据.
主要成果:
- 该模型在GDM诊断时达到82%的预测准确率,在分娩时达到91%.
- 新生儿不良后果发生在29%的队列中.
- 关键预测因素包括母亲的年龄,怀孕前的BMI和3小时口服葡萄糖耐受性测试结果.
结论:
- 开发的神经网络模型显示了预测GDM怀孕中新生儿不良结果的巨大潜力.
- 这种预测工具可以帮助临床医生识别高风险妊娠,以改善新生儿护理.
- 进一步验证和实施可以加强GDM的管理协议.
相关概念视频
Pathophysiology of Diabetes
950
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
950
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


